Epsilon Healthcare Ltd (EPN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.095x

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has a cash flow conversion efficiency ratio of -0.095x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-285.12K ≈ $-201.74K USD) by net assets (AU$2.99 Million ≈ $2.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Epsilon Healthcare Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Epsilon Healthcare Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Epsilon Healthcare Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Epsilon Healthcare Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nitro Games Oyj ST:NITRO	0.317x
WH Smith PLC LSE:SMWH	-0.025x
Pollen Street PLC LSE:POLN	0.069x
New Age Exploration Ltd AU:NAE	-0.044x
ICDS Limited NSE:ICDSLTD	0.021x
JPMorgan Claverhouse Investment Trust Plc LSE:JCH	0.020x
Auction Technology Group PLC LSE:ATG	0.068x
Great Western Exploration Ltd AU:GTE	-0.036x

Annual Cash Flow Conversion Efficiency for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Epsilon Healthcare Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see EPN stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$2.99 Million ≈ $2.11 Million	AU$-3.13 Million ≈ $-2.21 Million	-1.046x	-228.51%
2024-12-31	AU$10.70 Million ≈ $7.57 Million	AU$-3.41 Million ≈ $-2.41 Million	-0.318x	-241.31%
2023-12-31	AU$7.54 Million ≈ $5.33 Million	AU$-703.37K ≈ $-497.68K	-0.093x	+66.36%
2022-12-31	AU$9.27 Million ≈ $6.56 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.277x	+0.04%
2021-12-31	AU$19.57 Million ≈ $13.85 Million	AU$-5.43 Million ≈ $-3.84 Million	-0.277x	+19.21%
2020-12-31	AU$25.32 Million ≈ $17.91 Million	AU$-8.69 Million ≈ $-6.15 Million	-0.343x	+2.43%
2019-12-31	AU$22.32 Million ≈ $15.79 Million	AU$-7.86 Million ≈ $-5.56 Million	-0.352x	-68.97%
2018-12-31	AU$28.09 Million ≈ $19.87 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.208x	-136.88%
2017-12-31	AU$21.36 Million ≈ $15.11 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.088x	-574.77%
2016-12-31	AU$11.34 Million ≈ $8.03 Million	AU$-147.81K ≈ $-104.58K	-0.013x	--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$6.06 Million

AU$8.56 Million AUD

Market Cap Rank

#28184 Global

#1483 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$1.08